Big data and health data
The Big data phenomenon generates news ways of thinking and treating information. Indeed, the data volume situated in all datacenters around the planet is one source of future wealth. Many firms wish to use these data but they are confronting to data protection rights.
One Big data domain is a particular source of interest: health data .They represent a potential source of progress, especially in medical and epidemiology sciences. If professionals were able to analysis all existing health data on the planet, health research would have a great chance to prevent future cause of epidemic or pandemic diseases. Moreover, statistics based on these data would help to define evolution of disease and provide ways to protect population against it.
In 2009, American government worked with Google to prevent the H1N1 flu. This gave birth to a new web tool: Google Flutrends.
Furthermore, health data would enable the improvements of medical drug because firms would be able to adapt their production and their drug efficacy. They would be able to predict when and where people would need their products.
In summary, statistics based on health data would generate lot of profits and diminish stock and wastage.
However, web firms and pharmaceutical sector are confronted to Personal data obligations. As an example, in France, the CNIL’s regulation controls the use of personal data by firms, administrations and other organizations.
Health data are considered like sensitive data which must be protected against potential abuses of economical sectors.
So, the health data access is controlled and a legal frame is set. However, this legal frame is important in order to assure private life protection.
Despite these restraints, health big data market will continue to develop, especially with every connected object flooding the world economy.